A Review of the Economic Evaluation of Prolonged Release Melatonin (Circadin®) For The Short-Term Treatment of Primary Insomnia.
Pharmacoeconomic Evaluation
| Commenced | Completed | Outcome |
| August 2008 | October 2008 | Reimbursement not recommended. |
We believe that there is currently insufficient evidence to support the reimbursement of this product under the Community Drugs Schemes.